Back
GSK PLC Vs. Merck & Industry Stock Comparison
Sell
38
GSK
GSK PLC
Last Price:
$36.97
Seasonality Move:
3.98%
Sell
19
MRK
Merck &
Last Price:
$87.69
Seasonality Move:
2.49%
Sell
38
GSK PLC (GSK)
is a Sell
Is GSK PLC a Buy, Sell or Hold?
-
GSK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GSK Stock Price Chart
GSK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.63 | Buy |
Relative Strength Index (14 RSI): | 59.06 | Buy |
Chaikin Money Flow: | 980621 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
MRK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.94 | Sell |
Relative Strength Index (14 RSI): | 32.29 | Sell |
Chaikin Money Flow: | 16814923 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
GSK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.32 | Buy |
20-day SMA: | 35.62 | Buy |
50-day SMA: | 34.56 | Buy |
200-day SMA: | 38.72 | Sell |
8-day EMA: | 36.3 | Buy |
20-day EMA: | 35.69 | Buy |
50-day EMA: | 35.26 | Buy |
200-day EMA: | 37.34 | Sell |
MRK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 85.28 | Buy |
20-day SMA: | 91.49 | Sell |
50-day SMA: | 96.6 | Sell |
200-day SMA: | 112.11 | Sell |
8-day EMA: | 85.97 | Sell |
20-day EMA: | 90.06 | Sell |
50-day EMA: | 95.21 | Sell |
200-day EMA: | 106.74 | Sell |
GSK PLC Earnings Growth & GSK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.40 per share.
Merck & Earnings Growth & MRK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.89 per share, a decrease next quarter of $0.11 per share, an increase this year of $1.38 per share, and an increase next year of $0.92 per share.
GSK PLC Technical Analysis
Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
06 | 07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Merck & Technical Analysis
Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
06 | 07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |